Cetera Advisor Networks LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.

Quarter-by-quarter ownership
Cetera Advisor Networks LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$7,679,878
+10.6%
75,396
+9.6%
0.05%0.0%
Q2 2023$6,943,138
+21.0%
68,805
+10.3%
0.05%
+14.3%
Q1 2023$5,736,611
+2.0%
62,354
+0.6%
0.04%
-8.7%
Q4 2022$5,623,604
+101.1%
61,989
+68.5%
0.05%
+31.4%
Q3 2022$2,797,000
-1.6%
36,797
+9.4%
0.04%
-2.8%
Q2 2022$2,842,000
+9.5%
33,624
+13.7%
0.04%
+12.5%
Q1 2022$2,596,000
+4.6%
29,585
+4.2%
0.03%
+6.7%
Q4 2021$2,483,000
+8.1%
28,389
+1.1%
0.03%
-3.2%
Q3 2021$2,297,000
-11.7%
28,086
-1.4%
0.03%
-16.2%
Q2 2021$2,600,000
+295.1%
28,491
+270.0%
0.04%
+164.3%
Q1 2021$658,000
-37.0%
7,701
-30.4%
0.01%
-41.7%
Q4 2020$1,045,000
+4.0%
11,071
-4.2%
0.02%
-7.7%
Q3 2020$1,005,000
-10.0%
11,560
-9.6%
0.03%
-13.3%
Q2 2020$1,117,000
+4.8%
12,789
-1.0%
0.03%
-14.3%
Q1 2020$1,066,000
-12.6%
12,923
+0.5%
0.04%
+6.1%
Q4 2019$1,220,000
+11.5%
12,862
+2.4%
0.03%0.0%
Q3 2019$1,094,000
-10.1%
12,557
-6.0%
0.03%
-10.8%
Q2 2019$1,217,000
-3.7%
13,363
+1.6%
0.04%
-9.8%
Q1 2019$1,264,000
+4.4%
13,148
-6.8%
0.04%
-12.8%
Q4 2018$1,211,000
-8.5%
14,100
-8.1%
0.05%
+2.2%
Q3 2018$1,323,000
+35.6%
15,340
+19.1%
0.05%
-6.1%
Q2 2018$976,000
-4.7%
12,881
+1.6%
0.05%
+8.9%
Q1 2018$1,024,000
+26.7%
12,675
+31.4%
0.04%
+32.4%
Q4 2017$808,000
-7.3%
9,646
-4.4%
0.03%
-15.0%
Q3 2017$872,000
+6.5%
10,092
+3.2%
0.04%
+2.6%
Q2 2017$819,000
+11.9%
9,782
-0.9%
0.04%
+11.4%
Q1 2017$732,000
+5.9%
9,870
+4.3%
0.04%
-2.8%
Q4 2016$691,000
-39.6%
9,465
-34.7%
0.04%
-18.2%
Q3 2016$1,144,000
+41.6%
14,490
+47.7%
0.04%
-6.4%
Q2 2016$808,000
+3.3%
9,808
-9.2%
0.05%
-4.1%
Q1 2016$782,000
-4.4%
10,802
+14.0%
0.05%
-5.8%
Q4 2015$818,000
-14.6%
9,479
-9.3%
0.05%
-20.0%
Q3 2015$958,000
-11.7%
10,454
-4.4%
0.06%
-7.1%
Q2 2015$1,085,0000.0%10,9300.0%0.07%0.0%
Q1 2015$1,085,000
-1.7%
10,930
-8.3%
0.07%
-10.3%
Q4 2014$1,104,000
-6.9%
11,914
-5.9%
0.08%
-3.7%
Q3 2014$1,186,000
-20.7%
12,661
-23.6%
0.08%
-17.3%
Q2 2014$1,496,000
+10.5%
16,574
+4.9%
0.10%
+1.0%
Q1 2014$1,354,000
+17.3%
15,793
+9.5%
0.10%
+10.2%
Q4 2013$1,154,000
+7.0%
14,420
+3.0%
0.09%
-5.4%
Q3 2013$1,079,000
+2.4%
13,998
-6.4%
0.09%
-11.4%
Q2 2013$1,054,000
+1.4%
14,948
+2.0%
0.10%0.0%
Q1 2013$1,039,00014,6580.10%
Other shareholders
NOVARTIS A G shareholders Q1 2022
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders